Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2
Author:
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology
Reference60 articles.
1. The diverse functions of the PD1 inhibitory pathway;Sharpe;Nat. Rev. Immunol.,2018
2. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012
3. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial;Rizvi;Lancet Oncol.,2015
4. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N. Engl. J. Med.,2015
5. Immuno-oncology drug development goes global;Xin Yu;Nat. Rev. Drug Discov.,2019
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets;Experimental Hematology & Oncology;2024-08-30
2. Targeted protein editing technique in living mammalian cells by peptide-fused PNGase;hLife;2024-07
3. Doxorubicin induces deglycosylation of cancer cell‐intrinsic PD‐1 by NGLY1;FEBS Letters;2024-05-23
4. USP7 interacts with and destabilizes oncoprotein SET;Biochemical and Biophysical Research Communications;2024-05
5. Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways;Experimental Hematology & Oncology;2024-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3